Valuation: Ipsen

Market Cap 13.61B 15.89B 12.73B 11.64B 21.98B 1,516B 22.18B 150B 58.51B 765B 59.64B 58.34B 2,530B P/E 2026 *
13.8x
P/E 2027 * 14.1x
Enterprise Value 12.37B 14.45B 11.57B 10.58B 19.99B 1,378B 20.16B 137B 53.19B 695B 54.22B 53.03B 2,300B EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.44x
Free-Float
40.65%
Yield 2026 *
0.92%
Yield 2027 * 0.92%
1 day+2.09%
1 week+2.79%
Current month-0.72%
1 month+4.80%
3 months+3.62%
6 months+3.94%
Current year+39.50%
1 week 160.3
Extreme 160.3
167.4
1 month 153.1
Extreme 153.1
174
Current year 116
Extreme 116
174
1 year 109.9
Extreme 109.9
174
3 years 87.95
Extreme 87.95
174
5 years 77
Extreme 77
174
10 years 34.2
Extreme 34.2
174
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-30
Chief Executive Officer 57 2019-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 2005-08-29
Chairman 68 2010-11-21
Director/Board Member 69 2012-05-31
Date Insider Type Main position Quantity % Market Cap.
8/18/26 Sell

Chief Executive Officer

-1,000 0.0012%
8/17/26 Sell

Chief Executive Officer

-2,000 0.0024%
8/7/26 Sell

Chief Executive Officer

-14,300 0.0171%
Change 5-day change 1-year change 3-year change Capi.($)
+2.09%+2.79%+42.25%+40.92% 15.56B
-1.06%+4.27%+73.34%+125.12% 1,111B
+0.53%+4.10%+52.35%+65.45% 658B
+0.48%+6.18%+26.21%+81.27% 467B
+0.92%+4.97%+42.94%+43.69% 369B
+1.25%+4.00%+25.87%+42.82% 301B
+3.02%+7.92%+4.24%+16.06% 256B
-0.36%+5.45%+50.57%+72.33% 240B
+2.86%+5.27%-15.42%-52.34% 207B
+1.38%+7.09%+29.62%+94.90% 182B
Average +1.24%+4.11%+33.20%+53.02% 380.66B
Weighted average by Cap. +1.04%+4.66%+44.11%+72.94%

Financials

2026 *2027 *
Net sales 4.54B 5.3B 4.25B 3.89B 7.34B 506B 7.4B 50.14B 19.53B 255B 19.91B 19.48B 844B 4.64B 5.41B 4.34B 3.97B 7.49B 516B 7.56B 51.17B 19.94B 260B 20.32B 19.88B 862B
Net income 1.01B 1.18B 946M 865M 1.63B 113B 1.65B 11.15B 4.35B 56.78B 4.43B 4.33B 188B 985M 1.15B 922M 843M 1.59B 110B 1.61B 10.87B 4.24B 55.36B 4.32B 4.22B 183B
Net Debt -1.24B -1.45B -1.16B -1.06B -2B -138B -2.02B -13.66B -5.32B -69.54B -5.43B -5.31B -230B -2.3B -2.68B -2.15B -1.97B -3.71B -256B -3.75B -25.38B -9.89B -129B -10.08B -9.86B -427B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
26-08-25 €166.00 +2.09% 59,289
26-08-24 €162.60 -0.49% 66,193
26-08-21 €163.40 0.00% 53,626
26-08-20 €163.40 -1.03% 94,571
26-08-19 €165.10 +0.86% 72,813
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
166.00EUR
Average target price
167.07EUR
Spread / Average Target
+0.64%

Quarterly revenue - Rate of surprise